Scientific American - USA (2020-05)

(Antfer) #1
4 Scientific American, May 2020

FROM
THE EDITOR

BOARD OF ADVISERS
Leslie C. Aiello
President, Wenner-Gren Foundation
for Anthropological Research
Robin E. Bell
Research Professor, Lamont-Doherty
Earth Observatory, Columbia University
Emery N. Brown
Edward Hood Taplin Professor
of Medical Engineering and of
Computational Neuro science, M.I.T.,
and Warren M. Zapol Prof essor of
Anesthesia, Harvard Medical School
Vinton G. Cerf
Chief Internet Evangelist, Google
Emmanuelle Charpentier
Scientific Director, Max Planck Institute
for Infection Biology, and Founding
and Acting Director, Max Planck Unit
for the Science of Pathogens
George M. Church
Director, Center for Computational
Genetics, Harvard Medical School
Rita Colwell
Distinguished University Professor,
University of Maryland College Park
and Johns Hopkins Bloomberg School
of Public Health
Kate Crawford
Director of Research and Co-founder,
AI Now Institute, and Distinguished
Research Professor, New York University,
and Principal Researcher,
Microsoft Research New York City

Drew Endy
Professor of Bioengineering,
Stanford University
Nita A. Farahany
Professor of Law and Philosophy,
Director, Duke Initiative for
Science & Society, Duke University
Edward W. Felten
Director, Center for Information
Technology Policy, Princeton University
Jonathan Foley
Executive Director, Project Drawdown
Jennifer Francis
Senior Scientist,
Woods Hole Research Center
Kaigham J. Gabriel
President and Chief Executive Officer,
Charles Stark Draper Laboratory
Harold “Skip” Garner
Executive Director and Professor, Primary
Care Research Network and Center for
Bioinformatics and Genetics, Edward Via
College of Osteopathic Medicine
Michael S. Gazzaniga
Director, Sage Center for the Study of
Mind, University of California,
Santa Barbara
Carlos Gershenson
Research Professor, National
Autonomous University of Mexico

Alison Gopnik
Professor of Psychology and
Affiliate Professor of Philosophy,
University of California, Berkeley
Lene Vestergaard Hau
Mallinckrodt Professor of Physics and
of Applied Physics, Harvard University
Hopi E. Hoekstra
Alexander Agassiz Professor of Zoology,
Harvard University
Ayana Elizabeth Johnson
Founder and CEO, Ocean Collectiv
Christof Koch
President and CSO,
Allen Institute for Brain Science
Morten L. Kringelbach
Associate Professor and
Senior Research Fellow, The Queen’s
College, University of Oxford
Robert S. Langer
David H. Koch Institute Professor,
Department of Chemical Engineering,
M .I.T.
Meg Lowman
Director and Founder, TREE Foundation,
Rachel Carson Fellow, Ludwig Maximilian
University Munich, and Research
Professor, University of Science Malaysia
John Maeda
Global Head, Computational Design +
Inclusion, Automattic, Inc.

Satyajit Mayor
Senior Professor,
National Center for Biological Sciences,
Tata Institute of Fundamental Research
John P. Moore
Professor of Microbiology and
Immunology, Weill Medical College
of Cornell University
Priyamvada Natarajan
Professor of Astronomy and Physics,
Yale University
Donna J. Nelson
Professor of Chemistry,
University of Oklahoma
Robert E. Palazzo
Dean, University of Alabama at
Birmingham College of Arts and Sciences
Rosalind Picard
Professor and Director,
Affective Computing, M.I.T. Media Lab
Carolyn Porco
Leader, Cassini Imaging Science Team,
and Director, CICLOPS,
Space Science Institute
Lisa Randall
Professor of Physics, Harvard University
Martin Rees
Astronomer Royal and Professor
of Cosmology and Astrophysics,
Institute of Astronomy,
University of Cambridge

Daniela Rus
Andrew (1956) and Erna Viterbi Professor
of Electrical Engineering and Computer
Science and Director, CSAIL, M.I.T.
Eugenie C. Scott
Chair, Advisory Council,
National Center for Science Education
Terry Sejnowski
Professor and Laboratory Head of
Computational Neurobiology Laboratory,
Salk Institute for Biological Studies
Meg Urry
Israel Munson Professor of Physics
and Astronomy, Yale University
Michael E. Webber
Co-director, Clean Energy Incubator,
and Associate Professor,
Department of Mechanical Engineering,
University of Texas at Austin
George M. Whitesides
Professor of Chemistry and Chemical
Biology, Harvard University
Amie Wilkinson
Professor of Mathematics,
University of Chicago
Anton Zeilinger
Professor of Quantum Optics, Quantum
Nanophysics, Quantum Information,
University of Vienna

Curtis Brainard is acting editor in chief of Scientific American.
Follow him on Twitter @cbrainard

Diseases


and Deadlines


Magazine issue closes are always hectic. We spend months
working on each edition, but then for one week, roughly six weeks
before publication, we have to triple-check each of the some 100
pages in the book and get them out the door in time to meet our
monthly printer deadline. This close is different.
As I write this letter, it’s 10 p.m. on Sunday, March 15. Last
Tuesday our parent company, Springer Nature, told everyone in
the New York City office that they could work from home because
of the spread of coronavirus, and nearly everyone has availed
themselves of the opportunity. On Wednesday the World Health
Organization announced that the outbreak was a global pan-
demic. On Friday—the day we started sending pages for this issue
to the printer—President Donald Trump declared a state of emer-
gency in the U.S. And today New York Mayor Bill de Blasio said
that public schools would close citywide.
So we’re putting this issue to bed remotely—for many of us,
with our kids running around wildly in the background. At the
same time, we must keep up the daily news operation online,
where you can find ongoing coverage of the coronavirus crisis, how
it’s impacting our lives and what’s being done to stop it (visit sciam.
com/coronavirusoutbreak for the latest). I’m not worried, because
we have an amazing staff and because it’s been done before. When
Hurricane Sandy battered New York in 2012, our office building


near the Holland Tunnel (we’ve since moved) was closed for a week.
Also, while coronavirus is the scourge of the moment, it’s
important to not lose sight of the perennial maladies that afflict
us. Between 40  million and 50  million people around the world
currently live with Alzheimer’s and related dementias, with more
than two million deaths annually. And unlike COVID-19 (“corona-
virus disease, 2019”), there’s no “flattening the curve” here. Ther-
apies for Alzheimer’s, let alone a cure, have proved elusive in the
more than 100 years since the ailment was first recognized. But as
we reveal in this year’s Future of Medicine report, “A New Era for
Alzheimer’s,” starting on page  26, scientists are at long last reas-
sessing the basic physiology and biology of the disorder to find
new paths forward ( page  30 ). Along the way, they are taking a close
look at the “amyloid hypothesis” that has dominated research in
the field for decades ( page 34 ) and paying more heed to under-
appreciated risk factors such as the ways that menopause may
explain the higher prevalence of dementia in women ( page  37 ) and
the role of air pollution in driving the disease forward ( page  42 ).
Will this ostensible inflection point finally lead to effective
treatments? It’s too soon to tell, but with guarded optimism we
carry on hoping for a breakthrough.
At least with coronavirus, we all have some agency over the
blight. Governments are enacting civic restrictions, and people
are undertaking “social distancing.” I hope these measures will
help, but current predictions suggest the pandemic will continue
for many months. Whatever the future may hold, stay safe and
trust in science, not fear, to guide the way. And remember, sub-
scribers have access to every issue online: visit sciam.com/digital-
access for more information.

Illustration by Nick Higgins
Free download pdf